Kynos Therapeutics

Developer of therapies for immunological diseases

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2020 groups2 employees language kynostx.com

Registered entities

Investor mix

4 investors on record; lead investors include Epidarex Capital.

Investor typeCountShare
Venture capital125%
Bank & private debt125%
Other / undisclosed250%
Coming soon